Colgate-Palmolive Company (NYSE:CL) was the target of unusually large options trading on Tuesday. Stock investors purchased 12,928 put options on the company. This represents an increase of approximately 560% compared to the typical volume of 1,959 put options.

Shares of Colgate-Palmolive (CL) opened at 71.30 on Friday. Colgate-Palmolive has a 52-week low of $63.43 and a 52-week high of $77.27. The company’s 50 day moving average price is $72.38 and its 200 day moving average price is $72.86. The firm has a market capitalization of $62.80 billion, a price-to-earnings ratio of 26.50 and a beta of 0.80.

Colgate-Palmolive (NYSE:CL) last announced its quarterly earnings data on Friday, July 21st. The company reported $0.72 EPS for the quarter, hitting the Zacks’ consensus estimate of $0.72. Colgate-Palmolive had a return on equity of 3,121.95% and a net margin of 15.83%. The company had revenue of $3.83 billion during the quarter, compared to the consensus estimate of $3.89 billion. During the same quarter last year, the company earned $0.70 EPS. The company’s quarterly revenue was down .5% on a year-over-year basis. Analysts forecast that Colgate-Palmolive will post $2.89 earnings per share for the current year.

The company also recently disclosed a quarterly dividend, which was paid on Tuesday, August 15th. Shareholders of record on Tuesday, July 18th were given a $0.40 dividend. The ex-dividend date of this dividend was Friday, July 14th. This represents a $1.60 dividend on an annualized basis and a dividend yield of 2.24%. Colgate-Palmolive’s dividend payout ratio is currently 59.48%.

CL has been the topic of several recent research reports. Bank of America Corporation boosted their price target on Colgate-Palmolive from $78.00 to $80.00 and gave the stock a “buy” rating in a research report on Wednesday, May 31st. Zacks Investment Research raised Colgate-Palmolive from a “hold” rating to a “buy” rating and set a $83.00 price target on the stock in a research report on Tuesday, July 4th. Jefferies Group LLC boosted their price target on Colgate-Palmolive from $76.00 to $77.00 and gave the stock a “hold” rating in a research report on Thursday, July 6th. Royal Bank Of Canada reissued a “hold” rating and set a $74.00 price target on shares of Colgate-Palmolive in a research report on Monday, April 24th. Finally, Vetr lowered Colgate-Palmolive from a “buy” rating to a “hold” rating and set a $76.67 price target on the stock. in a research report on Wednesday, May 17th. Two equities research analysts have rated the stock with a sell rating, twelve have given a hold rating and two have issued a buy rating to the company. The company presently has an average rating of “Hold” and an average target price of $75.82.

In related news, insider Patricia Verduin sold 3,833 shares of the business’s stock in a transaction that occurred on Thursday, June 15th. The stock was sold at an average price of $75.67, for a total transaction of $290,043.11. Following the transaction, the insider now directly owns 53,022 shares of the company’s stock, valued at approximately $4,012,174.74. The transaction was disclosed in a filing with the Securities & Exchange Commission, which is accessible through this hyperlink. Also, COO Justin Skala sold 74,374 shares of the business’s stock in a transaction that occurred on Thursday, July 27th. The stock was sold at an average price of $72.51, for a total value of $5,392,858.74. Following the transaction, the chief operating officer now directly owns 97,177 shares in the company, valued at $7,046,304.27. The disclosure for this sale can be found here. Insiders have sold a total of 221,802 shares of company stock valued at $15,983,976 in the last quarter. Company insiders own 1.02% of the company’s stock.

Several hedge funds have recently made changes to their positions in CL. American Beacon Advisors Inc. purchased a new stake in shares of Colgate-Palmolive during the first quarter worth approximately $102,000. Proficio Capital Partners LLC increased its stake in shares of Colgate-Palmolive by 16.9% in the first quarter. Proficio Capital Partners LLC now owns 1,432 shares of the company’s stock worth $107,000 after buying an additional 207 shares in the last quarter. OLD Second National Bank of Aurora purchased a new stake in shares of Colgate-Palmolive during the second quarter worth approximately $109,000. Krilogy Financial LLC increased its stake in shares of Colgate-Palmolive by 23.0% in the second quarter. Krilogy Financial LLC now owns 1,547 shares of the company’s stock worth $115,000 after buying an additional 289 shares in the last quarter. Finally, Hanson & Doremus Investment Management increased its stake in shares of Colgate-Palmolive by 4.5% in the second quarter. Hanson & Doremus Investment Management now owns 1,630 shares of the company’s stock worth $121,000 after buying an additional 70 shares in the last quarter. Institutional investors own 73.69% of the company’s stock.

ILLEGAL ACTIVITY NOTICE: “Colgate-Palmolive Sees Unusually Large Options Volume (CL)” was posted by The Cerbat Gem and is the sole property of of The Cerbat Gem. If you are reading this piece of content on another website, it was copied illegally and republished in violation of United States and international trademark and copyright law. The original version of this piece of content can be read at https://www.thecerbatgem.com/2017/08/18/colgate-palmolive-sees-unusually-large-options-volume-cl.html.

Colgate-Palmolive Company Profile

Colgate-Palmolive Company (Colgate) is a consumer products company. The Company operates in two product segments: Oral, Personal and Home Care, and Pet Nutrition. The Oral, Personal and Home Care product segment is operated through five geographic segments, which include North America, Latin America, Europe, Asia Pacific and Africa/Eurasia.

Receive News & Stock Ratings for Colgate-Palmolive Company Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Colgate-Palmolive Company and related stocks with our FREE daily email newsletter.